These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12098730)

  • 21. Justice for the professional guinea pig.
    Lemmens T; Elliott C
    Am J Bioeth; 2001; 1(2):51-3. PubMed ID: 11951892
    [No Abstract]   [Full Text] [Related]  

  • 22. Doctors' links with investors raise concerns.
    Saul S; Anderson J
    N Y Times Web; 2005 Aug; ():A1,C6. PubMed ID: 16134280
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug companies cut costs with foreign clinical trials.
    Rai S
    N Y Times Web; 2005 Feb; ():C4. PubMed ID: 15742516
    [No Abstract]   [Full Text] [Related]  

  • 24. Ethics and industry-sponsored research.
    Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
    CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
    [No Abstract]   [Full Text] [Related]  

  • 25. Exploring the link between industry payments to doctors and prescribing habits.
    Carlat D
    BMJ; 2014 Nov; 349():g6651. PubMed ID: 25378357
    [No Abstract]   [Full Text] [Related]  

  • 26. Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility.
    Lièvre M; Ménard J; Bruckert E; Cogneau J; Delahaye F; Giral P; Leitersdorf E; Luc G; Masana L; Moulin P; Passa P; Pouchain D; Siest G
    BMJ; 2001 Mar; 322(7286):603-5. PubMed ID: 11238162
    [No Abstract]   [Full Text] [Related]  

  • 27. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biased articles.
    Friedman JH
    Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
    [No Abstract]   [Full Text] [Related]  

  • 29. Money, consent, and exploitation in research.
    Ashcroft RE
    Am J Bioeth; 2001; 1(2):62-3. PubMed ID: 11951898
    [No Abstract]   [Full Text] [Related]  

  • 30. Research participation and financial inducements.
    Resnik DB
    Am J Bioeth; 2001; 1(2):54-6. PubMed ID: 11951894
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulating the market in human research participants.
    Lemmens T; Miller PB
    PLoS Med; 2006 Aug; 3(8):e330. PubMed ID: 16866575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is informed consent enough? Monetary incentives for research participation and the integrity of biomedicine.
    Kuczewski M
    Am J Bioeth; 2001; 1(2):49-51. PubMed ID: 11951891
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug companies will have to report all payments to US doctors from March 2014.
    Roehr B
    BMJ; 2013 Feb; 346():f826. PubMed ID: 23393117
    [No Abstract]   [Full Text] [Related]  

  • 34. Patients, physicians, and clinical trials: the other side of the coins.
    Abramson SB; Flexner C; Snyderman R; Dieterich DT; Korn D; Temple R; Sherwood L; Goldblatt D
    J Investig Med; 1999 Sep; 47(8):343-57. PubMed ID: 10510587
    [No Abstract]   [Full Text] [Related]  

  • 35. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 36. Medical ethics, research and the pharmaceutical industry.
    Abud-Mendoza C
    Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
    [No Abstract]   [Full Text] [Related]  

  • 37. MSJAMA: Industry funding of clinical trials: benefit or bias?
    Chopra SS
    JAMA; 2003 Jul; 290(1):113-4. PubMed ID: 12837722
    [No Abstract]   [Full Text] [Related]  

  • 38. Can patients be asked to pay for experimental treatment?
    Lind SE
    Clin Res; 1984 Oct; 32(4):393-8. PubMed ID: 6509865
    [No Abstract]   [Full Text] [Related]  

  • 39. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
    Ferris LE
    CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
    [No Abstract]   [Full Text] [Related]  

  • 40. On considering (what I might do for) money.
    Heath E
    Am J Bioeth; 2001; 1(2):63-4. PubMed ID: 11951899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.